Dr Bryan Deane talks us through how the process of researching and developing a new medicine gets started.
Dr Sheuli Porkess talks us through how potential new medicines and vaccines go through rigorous clinical trials.
Dr Ali Hansford looks at what the future hold for medicines research and the treatments on the horizon.
The first step is to identify the target; maybe a cell receptor or an enzyme or a gene that’s involved in the disease process. The next challenge is to find something which affects that target to interfere with or prevent the development of disease or symptoms.
We sometimes have to test tens of thousands of molecules either through computer modelling, or in test tubes or cell cultures or in animals to identify a few that are effective enough to take forward to trial in patients.
The biopharmaceutical industry invests more than anyone else in research and development.
New science is becoming more and more precise. Despite the fact that failure rates are still high we’re learning about disease all the time and when we do have successes, we’re bringing improvements to the lives of millions of patients around the world.
MMIP represents the voice of medicines manufacturers in the UK. It was established jointly by the Government and the biopharmaceutical industry in 2014 to ensure that the UK is recognised by the global medicines industry as a world-class advanced centre for medicines manufacturing.
Clinical trials are important for patients, they are beneficial to the NHS and they are good for the UK economy.
The UK biopharmaceutical industry has a long and proud record of high quality, reliable manufacturing of medicinal products The UK medicines industry is one of our leading manufacturing sectors, with exports worth £24 billion and generating a trade surplus of £4.9 billion in 2012.
On average, it takes over 12 years and costs over £1 billion to develop new medicines. Can't believe it? Take a look at our 'time to flourish' infographic.
The overarching aim of our work in this area is to catalyse a transformation in innovation within the UK-based life science arena, improving the productivity of the research and development process and reinforcing the UK’s global role and influence
Research involving animals is a vital part of biomedical research and medicine development, helping us to understand and improve the prevention and treatment of diseases in animals and humans.
eHealth data refers to any data that has a heath related aspect and is stored and captured electronically.
We work with members and key partners to enhance the clinical research environment in the UK, striving to be competitive within Europe for initiating and completing valuable research.
Clinical trials are the cornerstone of the research and development process and it is through trials that pharmaceutical companies are able to demonstrate the safety and efficacy of new medicines.